Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care

Key PointsJohnson & Johnson’s JNJ-6143 posted excellent results in an early-stage clinical trial.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Health & Medicine

THE SHAME OF CHOLERA OUTBREAKS

Health authorities must do more to contain the scourge Despite a recent warning by the Nigeria Centre for Disease Control and Prevention (NCDC) that cholera transmission peaks between late August

More from Friday 20 November →